[Treatment of dystonia].
Mezaki
Takahiro
T
Department of Neurology, Sakaki-bara Hakuho Hospital, 5630 Sakakibara-cho, Hisai-shi, Mie 514-1251, Japan.
D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use*; D001764:Blepharospasm / Q000628:therapy; D001905:Botulinum Toxins / Q000627:therapeutic use; D004421:Dystonia / Q000534:rehabilitation / Q000601:surgery / Q000628:therapy; D020821:Dystonic Disorders / Q000534:rehabilitation / Q000601:surgery / Q000628:therapy*; D006801:Humans; D009407:Nerve Block; D011613:Psychotherapy; D014103:Torticollis / Q000628:therapy; D050781:Transcranial Magnetic Stimulation
D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins